{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:16:18Z","timestamp":1787062578227,"version":"build-2736575974"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaut.2018.07.016","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T01:09:05Z","timestamp":1532653745000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus"],"prefix":"10.1016","volume":"93","author":[{"given":"Simran Kaur","family":"Nahal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.07.016_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.02.003","article-title":"Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: a comprehensive review","volume":"69","author":"Gatto","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2016.04.005","article-title":"Autoimmunity, neuroinflammation, pathogen load: a decisive crosstalk in neuropsychiatric SLE","volume":"74","author":"Jeltsch-David","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaut.2016.12.005","article-title":"Pathways of impending disease flare in African-American systemic lupus erythematosus patients","volume":"78","author":"Munroe","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.010","article-title":"Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study","volume":"74","author":"Moroni","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib5","first-page":"37","article-title":"Management of systemic lupus erythematosus during pregnancy: challenges and solutions","volume":"9","author":"Knight","year":"2017","journal-title":"Open Access Rheumatol. Res. Rev."},{"key":"10.1016\/j.jaut.2018.07.016_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaut.2016.06.016","article-title":"A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus","volume":"74","author":"Lazzaroni","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2017.01.004","article-title":"Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus","volume":"79","author":"Reed","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2362.2010.02443.x","article-title":"Lupus and pregnancy: integrating clues from the bench and bedside","volume":"41","author":"Ruiz-Irastorza","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.07.016_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2017.02.009","article-title":"Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016","volume":"79","author":"Bundhun","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaut.2017.01.008","article-title":"Maternal-foetal outcomes in pregnant women with glomerulonephritides. Are all glomerulonephritides alike in pregnancy?","volume":"79","author":"Piccoli","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaut.2017.06.003","article-title":"Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis?","volume":"84","author":"Gianfreda","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2013.05.006","article-title":"Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy","volume":"149","author":"Barbhaiya","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2016.07.001","article-title":"The diagnosis and management of the haematologic manifestations of lupus","volume":"74","author":"Velo-Garcia","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1191\/096120399680411272","article-title":"Assessing disease activity in SLE patients during pregnancy","volume":"8","author":"Buyon","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaut.2016.06.012","article-title":"Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study","volume":"74","author":"Moroni","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-014-8572-6","article-title":"Predictors of maternal and fetal complications in SLE patients: a prospective study","volume":"60","author":"Borella","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2018.07.016_bib17","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/acr.22791","article-title":"What to expect when expecting with systemic lupus erythematosus (SLE): a population-based study of maternal and fetal outcomes in SLE and pre-SLE","volume":"68","author":"Arkema","year":"2016","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2018.07.016_bib18","doi-asserted-by":"crossref","unstructured":"Chakravarty EF, Col\u00f3n I, Langen ES, Nix DA, El-Sayed YY, Genovese MC et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am. J. Obstet. Gynecol.;192:1897-1904.","DOI":"10.1016\/j.ajog.2005.02.063"},{"key":"10.1016\/j.jaut.2018.07.016_bib19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.kint.2015.10.012","article-title":"Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease","volume":"89","author":"Bramham","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2018.07.016_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmg026","article-title":"The immunology of successful pregnancy","volume":"9","author":"Veenstra van Nieuwenhoven","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jaut.2018.07.016_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1191\/0961203304lu1094oa","article-title":"Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity","volume":"13","author":"Cutolo","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1196\/annals.1351.033","article-title":"Cytokines and pregnancy in rheumatic disease","volume":"1069","author":"Ostensen","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2018.07.016_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0167-5699(93)90235-D","article-title":"Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?","volume":"14","author":"Wegmann","year":"1993","journal-title":"Immunol. today"},{"key":"10.1016\/j.jaut.2018.07.016_bib24","doi-asserted-by":"crossref","first-page":"A437","DOI":"10.1016\/j.autrev.2011.11.013","article-title":"Interaction of pregnancy and autoimmune rheumatic disease","volume":"11","author":"Ostensen","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.016_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0897.2011.00987.x","article-title":"Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia","volume":"66","author":"Toldi","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"issue":"Suppl 3","key":"10.1016\/j.jaut.2018.07.016_bib26","article-title":"Challenges of lupus pregnancies","volume":"47","author":"Doria","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.016_bib27","doi-asserted-by":"crossref","first-page":"J197","DOI":"10.1016\/j.jaut.2011.11.010","article-title":"Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome","volume":"38","author":"Andreoli","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K","article-title":"Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture","volume":"41","author":"Reveille","year":"1998","journal-title":"Arthritis and rheumatism"},{"key":"10.1016\/j.jaut.2018.07.016_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/1529-0131(199807)41:7<1173::AID-ART5>3.0.CO;2-A","article-title":"Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture","volume":"41","author":"Alarcon","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.016_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/096120399678847704","article-title":"Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture","volume":"8","author":"Alarcon","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1529-0131(199908)12:4<256::AID-ART4>3.0.CO;2-G","article-title":"Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture","volume":"12","author":"Friedman","year":"1999","journal-title":"Arthritis Care Res. Offic. J. Arthritis Health Prof. Assoc."},{"key":"10.1016\/j.jaut.2018.07.016_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/1529-0131(199908)12:4<267::AID-ART5>3.0.CO;2-9","article-title":"Systemic lupus erythematosus in three ethnic groups. V. Acculturation, health-related attitudes and behaviors, and disease activity in Hispanic patients from the LUMINA cohort. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture","volume":"12","author":"Alarcon","year":"1999","journal-title":"Arthritis Care Res. Offic. J. Arthritis Health Prof. Assoc."},{"key":"10.1016\/j.jaut.2018.07.016_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1191\/096120300678828046","article-title":"Systemic lupus erythematosus in three ethnic groups. VI: factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture","volume":"9","author":"Zonana-Nacach","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1529-0131(200104)45:2<191::AID-ANR173>3.0.CO;2-2","article-title":"Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group","volume":"45","author":"Alarcon","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.016_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/1529-0131(200104)44:4<981::AID-ANR158>3.0.CO;2-0","article-title":"Systemic lupus erythematosus in three ethnic groups. VIII. Lack of association of glutathione S-transferase null alleles with disease manifestations","volume":"44","author":"Tew","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.016_bib36","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/1529-0131(200112)44:12<2797::AID-ART467>3.0.CO;2-9","article-title":"Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual","volume":"44","author":"Alarcon","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.016_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1191\/0961203302lu158oa","article-title":"Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis","volume":"11","author":"Bastian","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib38","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/rheumatology\/kel222","article-title":"Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII)","volume":"45","author":"Andrade","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.016_bib39","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajog.2005.02.063","article-title":"Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus","volume":"192","author":"Chakravarty","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jaut.2018.07.016_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jaut.2018.07.016_bib41","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1177\/0961203315586455","article-title":"Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancy","volume":"24","author":"Tedeschi","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7150\/ijms.8.577","article-title":"Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE","volume":"8","author":"Ko","year":"2011","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jaut.2018.07.016_bib43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10067-012-1941-4","article-title":"Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy","volume":"31","author":"Saavedra","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib44","doi-asserted-by":"crossref","first-page":"127 e1","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jaut.2018.07.016_bib45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.berh.2017.09.011","article-title":"Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome","volume":"31","author":"Fischer-Betz","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib46","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol. : CJASN"},{"key":"10.1016\/j.jaut.2018.07.016_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2018.07.016_bib48","article-title":"An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus","author":"Teng","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.016_bib49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/BOR.0000000000000415","article-title":"Pregnancy and reproductive aspects of systemic lupus erythematosus","volume":"29","author":"Andreoli","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/IJWH.S90157","article-title":"Systemic lupus erythematosus: strategies to improve pregnancy outcomes","volume":"8","author":"Yamamoto","year":"2016","journal-title":"Int. J. Wom. Health"},{"key":"10.1016\/j.jaut.2018.07.016_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.rdc.2007.01.002","article-title":"Lupus activity in pregnancy","volume":"33","author":"Clowse","year":"2007","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jaut.2018.07.016_bib52","doi-asserted-by":"crossref","first-page":"e4407","DOI":"10.1097\/MD.0000000000004407","article-title":"Increased risk of systemic lupus erythematosus in pregnancy-induced hypertension: a nationwide population-based retrospective cohort study","volume":"95","author":"Lin","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jaut.2018.07.016_bib53","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/annrheumdis-2012-202449","article-title":"Predictors of preterm birth in patients with mild systemic lupus erythematosus","volume":"72","author":"Clowse","year":"2013","journal-title":"Annal. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.016_bib54","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.21663","article-title":"Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"Chakravarty","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.016_bib55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/aogs.12324","article-title":"Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry","volume":"93","author":"Wallenius","year":"2014","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jaut.2018.07.016_bib56","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3349\/ymj.2008.49.4.515","article-title":"Prognosis of neonates in pregnant women with systemic lupus erythematosus","volume":"49","author":"Kim","year":"2008","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.jaut.2018.07.016_bib57","article-title":"Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus","author":"Bakshi","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.semnephrol.2017.05.006","article-title":"Lupus nephritis and pregnancy: concerns and management","volume":"37","author":"Lightstone","year":"2017","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.jaut.2018.07.016_bib59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12016-016-8533-z","article-title":"Molecular and immunological basis of tubulo-interstitial injury in lupus nephritis: a comprehensive review","volume":"52","author":"Yung","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib60","first-page":"519","volume":"vol. 24","author":"Imbasciati","year":"2009"},{"key":"10.1016\/j.jaut.2018.07.016_bib61","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.11431116","article-title":"Kidney outcomes and risk factors for nephritis (Flare\/De novo) in a multiethnic cohort of pregnant patients with lupus","volume":"12","author":"Buyon","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol. : CJASN"},{"key":"10.1016\/j.jaut.2018.07.016_bib62","first-page":"2127","article-title":"Preterm deliveries in women with systemic lupus erythematosus","volume":"30","author":"Clark","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib63","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2796.2009.02100.x","article-title":"Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal\/foetal dyad at risk","volume":"265","author":"Buyon","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2018.07.016_bib64","first-page":"115","article-title":"Pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Practical messages from the EULAR guidelines","volume":"127","author":"Vagelli","year":"2017","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.jaut.2018.07.016_bib65","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Annal. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.016_bib66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48\u201349","author":"Gomez-Puerta","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12016-016-8569-0","article-title":"Pregnancy outcome in women with obstetric and thrombotic antiphospholipid syndrome-a retrospective analysis and a review of additional treatment in pregnancy","volume":"53","author":"Mayer-Pickel","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12016-009-8146-x","article-title":"Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome","volume":"38","author":"Blank","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.003","article-title":"The treatment of anti-phospholipid syndrome: a comprehensive clinical approach","volume":"90","author":"Chighizola","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib71","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11926-013-0405-4","article-title":"Management of recurrent thrombosis in antiphospholipid syndrome","volume":"16","author":"Nalli","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2018.07.016_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaut.2009.05.002","article-title":"Management of antiphospholipid syndrome","volume":"33","author":"Tuthill","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11926-018-0718-4","article-title":"Update on antiphospholipid syndrome: ten topics in 2017","volume":"20","author":"Cavazzana","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2018.07.016_bib74","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/0961203312451335","article-title":"Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study","volume":"21","author":"Fischer-Betz","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kex378","article-title":"The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies","volume":"57","author":"Schreiber","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.016_bib76","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0961203317724219","article-title":"Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease","volume":"27","author":"Erkan","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib77","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/annrheumdis-2016-210012","article-title":"Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase","volume":"76","author":"Muller-Calleja","year":"2017","journal-title":"Annal. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.016_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.07.003","article-title":"Prevention & treatment of obstetrical complications in APS: is hydroxychloroquine the Holy Grail we are looking for?","volume":"75","author":"Meroni","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib79","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2016.04.008","article-title":"Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome","volume":"75","author":"Bertolaccini","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib80","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.016_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib82","first-page":"279","volume":"vol. 23","author":"Brucato","year":"2002"},{"key":"10.1016\/j.jaut.2018.07.016_bib83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12016-017-8653-0","article-title":"Neonatal systemic lupus erythematosus syndrome: a comprehensive review","volume":"53","author":"Vanoni","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib84","first-page":"848","article-title":"Anti-Ro\/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group","volume":"32","author":"Scarsi","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib85","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaut.2009.06.005","article-title":"Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel","volume":"34","author":"Karnabi","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12016-017-8627-2","article-title":"The cutaneous spectrum of lupus erythematosus","volume":"53","author":"Ribero","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib87","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2017.02.010","article-title":"Neonatal lupus: follow-up in infants with anti-SSA\/Ro antibodies and review of the literature","volume":"16","author":"Zuppa","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.016_bib88","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1365-4632.2012.05809.x","article-title":"Cutaneous neonatal lupus: a case report and review of the literature","volume":"53","author":"Moretti","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib89","first-page":"298","article-title":"[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro\/SSA antibodies]","volume":"53","author":"Frassi","year":"2001","journal-title":"Reumatismo"},{"key":"10.1016\/j.jaut.2018.07.016_bib90","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zeron","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib91","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/rheumatology\/kex263","article-title":"Factors influencing fetal cardiac conduction in anti-Ro\/SSA-positive pregnancies","volume":"56","author":"Sonesson","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.016_bib92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00403-016-1622-2","article-title":"The high incidence of anti-Ro\/SSA and anti-p200 antibodies in female patients with connective tissue diseases confirms the importance of screening for congenital heart block-associated autoantibodies during pregnancy","volume":"308","author":"Cozzani","year":"2016","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jaut.2018.07.016_bib93","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12026-016-8888-5","article-title":"Obstetric and perinatal outcome in anti-Ro\/SSA-positive pregnant women: a prospective cohort study","volume":"65","author":"Martinez-Sanchez","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2018.07.016_bib94","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.autrev.2017.09.005","article-title":"Should we treat congenital heart block with fluorinated corticosteroids?","volume":"16","author":"Brucato","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.016_bib95","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","volume":"75","author":"Izmirly","year":"2016","journal-title":"Annal. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.016_bib96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2018.07.016_bib97","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Annal. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.016_bib98","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2017.07.100","article-title":"Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus","volume":"248","author":"Morel","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2018.07.016_bib99","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.30464","article-title":"Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block","volume":"63","author":"Routsias","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"Suppl 2","key":"10.1016\/j.jaut.2018.07.016_bib100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/AOG.0b013e3181e75a4a","article-title":"Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin","volume":"116","author":"David","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jaut.2018.07.016_bib104","doi-asserted-by":"crossref","first-page":"e000131","DOI":"10.1136\/lupus-2015-000131","article-title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results","volume":"3","author":"Yelnik","year":"2016","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2018.07.016_bib105","first-page":"1","article-title":"Preeclampsia in pregnancies complicated by systemic lupus erythematosus (SLE) nephritis: prophylactic treatment with multidisciplinary approach are important keys to prevent adverse obstetric outcomes","author":"Mecacci","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med. Offic. J. Eur. Assoc. Perinatal Med. Fed. Asia Oceania Perinatal Soc."},{"key":"10.1016\/j.jaut.2018.07.016_bib106","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.rdc.2016.12.009","article-title":"Systemic lupus erythematosus and pregnancy","volume":"43","author":"Lateef","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jaut.2018.07.016_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.12.011","article-title":"A comprehensive evaluation for the treatment of lupus nephritis","volume":"78","author":"Zampeli","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.016_bib108","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-016-8596-x","article-title":"Tumor necrosis factor-alpha and pregnancy: focus on biologics. An updated and comprehensive review","volume":"53","author":"Alijotas-Reig","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib109","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.016_bib110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Annal. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.016_bib111","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrrheum.2016.27","article-title":"Therapy: a fine conception \u2013 BSR\/BHPR guidelines on drugs in pregnancy","volume":"12","author":"Sammaritano","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib112","first-page":"561","article-title":"Medication use among pregnant women with systemic lupus erythematosus and general population comparators","volume":"56","author":"Palmsten","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.016_bib113","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1191\/0961203303lu393oa","article-title":"Treatment of pregnant patients with antiphospholipid syndrome","volume":"12","author":"Tincani","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib114","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1191\/096120300678828794","article-title":"Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus","volume":"9","author":"Ostensen","year":"2000","journal-title":"Lupus"},{"issue":"Suppl 3","key":"10.1016\/j.jaut.2018.07.016_bib115","article-title":"Prevention of congenital heart block in children of SSA-positive mothers","volume":"47","author":"Brucato","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.016_bib116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1546-0096-12-47","article-title":"Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and\/or low molecular weight heparin","volume":"12","author":"Pagnini","year":"2014","journal-title":"Pediatric Rheumatol. Online J."},{"key":"10.1016\/j.jaut.2018.07.016_bib117","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2810202","article-title":"Hydroxychloroquine use in lupus patients during pregnancy is associated with longer pregnancy duration in preterm births","volume":"2017","author":"Kroese","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2018.07.016_bib118","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1160\/th15-06-0491","article-title":"The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment","volume":"115","author":"Sciascia","year":"2016","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2018.07.016_bib119","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10067-015-2987-x","article-title":"Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome","volume":"34","author":"Saavedra","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib120","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/aji.12514","article-title":"The efficacy and safety of cyclosporin a in pregnant patients with systemic autoimmune diseases","volume":"75","author":"Reggia","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/s10165-010-0340-4","article-title":"Successful management of systemic lupus erythematosus nephritis flare-up during pregnancy with tacrolimus","volume":"21","author":"Alsuwaida","year":"2011","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.016_bib122","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0036-1597933","article-title":"What is the teratogenic risk of mycophenolate?","volume":"6","author":"Kylat","year":"2017","journal-title":"J. Pediatr. Genet."},{"key":"10.1016\/j.jaut.2018.07.016_bib123","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1191\/0961203303lu2004oa","article-title":"Disease specific problems related to drug therapy in pregnancy","volume":"13","author":"Ostensen","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.016_bib124","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/1744666X.2015.1033404","article-title":"Immunosuppression in pregnant women with systemic lupus erythematosus","volume":"11","author":"Ponticelli","year":"2015","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.016_bib125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2014.05.006","article-title":"Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report","volume":"44","author":"Danve","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.016_bib126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2013.03.001","article-title":"B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases","volume":"43","author":"Sangle","year":"2013","journal-title":"J. Autoimmun."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118302804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118302804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:21:15Z","timestamp":1760257275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118302804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":123,"alternative-id":["S0896841118302804"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.07.016","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}